With more than 20 years of experience in the field of microbial systems, Wacker Biotech GmbH is your partner for the contract-manufacturing of therapeutic proteins. We understand our customers’ requirements and know that quality and speed determine a project’s success ‒ regardless of whether you require the product for clinical testing purposes or for market supply.
One of our core skills is the GMP-compliant development of robust, high-efficiency processes. Our outstanding technologies can significantly contribute to your projects’ success and reduce the cost of goods. Our proprietary ESETEC® secretion technology enables highly efficient extracellular production of proteins using E. coli K12. The second-generation ESETEC® 2.0 secretion technology makes high product yields of several grams per liter possible.
The FOLDTEC® technology is based on proprietary E. coli strains optimized for high-quality inclusion bodies and superior yields (up to 12 grams per liter). Complemented by our years of experience in refolding and a tailored screening approach, FOLDTEC® offers better efficacies, smaller folding volumes and fully scalable manufacturing processes without the need for antibiotics or undesired phage components.
At our GMP-compliant production plants in Halle and Jena, we either work with these proprietary high-performance technologies, or we transfer your existing process to our facilities. Our focused teams identify critical process parameters and our project managers work closely with you to ensure that the project is executed as planned.